ReviewThe Lancet regional health. Southeast Asia2026
From DOTS to DOST: a new framework for TB elimination in India.
Review in The Lancet regional health. Southeast Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New tools and policies herald a major advance in tuberculosis diagnosis.The Indian journal of medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
India bears a quarter of the global tuberculosis (TB) burden and nearly one-third of TB related deaths, but substantial regional heterogeneity demands tailored elimination strategies. We propose the Dual-phase Operational Strategy for Tuberculosis elimination (DOST), a roadmap that explicitly addresses TB as both an infectious disease and a structural challenge. Phase 1 focuses on rapidly reducing transmission through intensified case-finding, upfront molecular diagnosis, and strengthened treatment, as demonstrated by India's 100-Day TB Campaign, which expanded community screening and accelerated therapy initiation. Phase 2 pivots to preventing disease progression by scaling up TB preventive treatment and addressing key drivers such as undernutrition, HIV, and diabetes. DOST emphasizes subnational adaptation: high-burden states prioritize disease reduction, while states nearing low incidence shift toward preventing flare-ups and sustaining progress. Rooted in the Hindi word dost (friend), this person-centered approach integrates medical and social support, recognizing that eliminating TB in India requires compassion paired with structural action. By sequencing and localizing proven interventions, DOST offers a pragmatic pathway from TB response to TB elimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.